Funding for this research was provided by:
U.S. Food and Drug Administration (U01 FD005946)
Article History
Accepted: 1 June 2022
First Online: 24 July 2022
Declarations
:
: This manuscript was supported by the US Food and Drug Administration (FDA), an agency within the Department of Health and Human Services (HHS), as part of a financial assistance award (FAIN) totaling US$60,617 with 8% funded by FDA/HHS and US$55,617 and 92% funded by nongovernment source(s). The contents are those of the author(s) and do not necessarily represent the official views of or an endorsement by either FDA/HHS or the US Government.
: The authors declare that they have no conflict of interest.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: BMK—Conception and design of research; acquisition, analysis, and interpretation of data; writing and revision of final manuscript. QH—Conception and design of research; interpretation of data; critical revision of final manuscript. MV-C—Conception and design of research; interpretation of data; critical revision of final manuscript. All authors have read and approved the final submitted manuscript and agree to be accountable for the work.